Vischini, Gisella
Vischini, Gisella
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
2020 Petricca, L.; Gigante, M. R.; Paglionico, A.; Costanzi, S.; Vischini, G.; Di Mario, C.; Varriano, V.; Tanti, G.; Tolusso, B.; Alivernini, S.; Grandaliano, G.; Ferraccioli, G.; Gremese, E.
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
2020 Petricca, L.; Gigante, M. R.; Paglionico, A.; Costanzi, S.; Vischini, G.; Di Mario, C.; Varriano, V.; Tanti, G.; Tolusso, B.; Alivernini, S.; Grandaliano, G.; Ferraccioli, G.; Gremese, E.
SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis
2020 Vischini, G.; D'Alonzo, S.; Grandaliano, G.; D'Ascenzo, F. M.
Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report
2019 Calvaruso, Luca; Naticchia, Alessandro; Ferraro, Pietro Manuel; Vischini, Gisella; Costanzi, Stefano
Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpura
2018 Milillo, A; Molinario, C; Costanzi, S; Vischini, G; La Carpia, F; La Greca, F; Rigante, D; Gambaro, G; Gurrieri, F; Sangiorgi, E.
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury
2018 Masola, Valentina; Zaza, Gianluigi; Bellin, Gloria; Dall'Olmo, Luigi; Granata, Simona; Vischini, Gisella; Secchi, Maria Francesca; Lupo, Antonio; Gambaro, Giovanni; Onisto, Maurizio
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury
2016 Masola, Valentina; Zaza, Gianluigi; Gambaro, Giovanni; Onisto, Maurizio; Bellin, Gloria; Vischini, Gisella; Khamaysi, Iyad; Hassan, Ahmad; Hamoud, Shadi; Nativ, Omri; N. Heyman, Samuel; Lupo, Antonio; Vlodavsky, Israel; Abassi, Zaid
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy.
2015 Sangiorgi, Eugenio; Gurrieri, Fiorella; Milillo, Annamaria; La Carpia, Francesca; Costanzi, Stefano; Martini, Maurizio; Larocca, Luigi Maria; Vischini, Gisella
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2020 | Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies | Petricca, L.; Gigante, M. R.; Paglionico, A.; Costanzi, S.; Vischini, G.; Di Mario, C.; Varriano, V.; Tanti, G.; Tolusso, B.; Alivernini, S.; Grandaliano, G.; Ferraccioli, G.; Gremese, E. | |
| 1-gen-2020 | Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies | Petricca, L.; Gigante, M. R.; Paglionico, A.; Costanzi, S.; Vischini, G.; Di Mario, C.; Varriano, V.; Tanti, G.; Tolusso, B.; Alivernini, S.; Grandaliano, G.; Ferraccioli, G.; Gremese, E. | |
| 1-gen-2020 | SARS-CoV-2 in the peritoneal waste in a patient treated with peritoneal dialysis | Vischini, G.; D'Alonzo, S.; Grandaliano, G.; D'Ascenzo, F. M. | |
| 1-gen-2019 | Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report | Calvaruso, Luca; Naticchia, Alessandro; Ferraro, Pietro Manuel; Vischini, Gisella; Costanzi, Stefano | |
| 1-gen-2018 | Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpura | Milillo, A; Molinario, C; Costanzi, S; Vischini, G; La Carpia, F; La Greca, F; Rigante, D; Gambaro, G; Gurrieri, F; Sangiorgi, E. | |
| 1-gen-2018 | Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury | Masola, Valentina; Zaza, Gianluigi; Bellin, Gloria; Dall'Olmo, Luigi; Granata, Simona; Vischini, Gisella; Secchi, Maria Francesca; Lupo, Antonio; Gambaro, Giovanni; Onisto, Maurizio | |
| 1-gen-2016 | Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury | Masola, Valentina; Zaza, Gianluigi; Gambaro, Giovanni; Onisto, Maurizio; Bellin, Gloria; Vischini, Gisella; Khamaysi, Iyad; Hassan, Ahmad; Hamoud, Shadi; Nativ, Omri; N. Heyman, Samuel; Lupo, Antonio; Vlodavsky, Israel; Abassi, Zaid | |
| 1-gen-2015 | A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. | Sangiorgi, Eugenio; Gurrieri, Fiorella; Milillo, Annamaria; La Carpia, Francesca; Costanzi, Stefano; Martini, Maurizio; Larocca, Luigi Maria; Vischini, Gisella |